is compounded semaglutide being banned FDA Ban on GLP-1 Drugs: What to Know Semaglutide for weight loss |
Description
, Trapp, S
The SCALE (Satiety and Clinical Adiposity - Liraglutide Evidence in Nondiabetic and Diabetic Individuals Obesity and Prediabetes) trial found a mean weight loss of 8% vs
Clinical trials have not identified increased urination as a significant adverse event requiring specific monitoring for GLP-1 receptor agonists
Weight regain can occur if medication is stopped without maintaining supportive lifestyle changes, as weight regulation is influenced by long-term metabolic factors
(Lausanne) 9, 233
Medication is a powerful tool, but our programs in Southlake are holistic
